UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors

Clinical science (1979), 2011-10, Vol.121 (7), p.297-303

2011

Volltextzugriff (PDF)

Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats

PloS one, 2014-04, Vol.9 (4), p.e95762

2014

Volltextzugriff (PDF)

Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis

Diabetes & vascular disease research, 2018-01, Vol.15 (1), p.64-73

2018

Volltextzugriff (PDF)

Optimising the photothrombotic model of stroke in the C57BI/6 and FVB/N strains of mouse

Scientific reports, 2022-05, Vol.12 (1), p.7598-7598, Article 7598

2022

Volltextzugriff (PDF)

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice

Arteriosclerosis, thrombosis, and vascular biology, 2010-08, Vol.30 (8), p.1606-1613

2010

Volltextzugriff (PDF)

Differential phenotypes of tissue-infiltrating T cells during angiotensin II-induced hypertension in mice

PloS one, 2014-12, Vol.9 (12), p.e114895-e114895

2014

Volltextzugriff (PDF)

The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model

Diabetes & vascular disease research, 2013-07, Vol.10 (4), p.353-360

2013

Volltextzugriff (PDF)

Nitroxyl (HNO): the Cinderella of the nitric oxide story

Trends in pharmacological sciences (Regular ed.), 2008-12, Vol.29 (12), p.601-608

2008

Volltextzugriff (PDF)

Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis

Kidney international, 2014-07, Vol.86 (1), p.75-85

2014

Volltextzugriff (PDF)

In Aged Females, the Enhanced Pressor Response to Angiotensin II Is Attenuated By Estrogen Replacement via an Angiotensin Type 2 Receptor-Mediated Mechanism

Hypertension (Dallas, Tex. 1979), 2021-07, Vol.78 (1), p.HYPERTENSIONAHA12117164-137

2021

Volltextzugriff (PDF)

The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice

International journal of molecular sciences, 2022-11, Vol.23 (22), p.14039

2022

Volltextzugriff (PDF)

Anti-fibrotic Potential of AT2 Receptor Agonists

Frontiers in pharmacology, 2017-08, Vol.8, p.564-564

2017

Volltextzugriff (PDF)

Novel AT2R agonist, β-Pro7Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats

Biomedicine & pharmacotherapy, 2023-09, Vol.165, p.115238-115238, Article 115238

2023

Volltextzugriff (PDF)

Protective arms of the renin-angiotensin-system in neurological disease

Clinical and experimental pharmacology & physiology, 2013-08, Vol.40 (8), p.580-588

2013

Volltextzugriff (PDF)

Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice

Biomedicine & pharmacotherapy, 2021-12, Vol.144, p.112256-112256, Article 112256

2021

Volltextzugriff (PDF)

Renal functional effects of the highly selective AT2R agonist, β-Pro7 Ang III, in normotensive rats

Clinical science (1979), 2020-04, Vol.134 (7), p.871-884

2020

Volltextzugriff (PDF)

Reversal of Vascular Macrophage Accumulation and Hypertension by a CCR2 Antagonist in Deoxycorticosterone/Salt-Treated Mice

Hypertension (Dallas, Tex. 1979), 2012-11, Vol.60 (5), p.1207-1212

2012

Volltextzugriff (PDF)

The protective effects of a novel AT2 receptor agonist, β-Pro7Ang III in ischemia-reperfusion kidney injury

Biomedicine & pharmacotherapy, 2023-05, Vol.161, p.114556-114556, Article 114556

2023

Volltextzugriff (PDF)

Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo

PloS one, 2015-11, Vol.10 (11), p.e0142087-e0142087

2015

Volltextzugriff (PDF)

The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy

Biomedicine & pharmacotherapy, 2023-04, Vol.160, p.114370-114370, Article 114370

2023

Volltextzugriff (PDF)

β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats

Clinical science (1979), 2015-09, Vol.129 (6), p.505-513

2015

Volltextzugriff (PDF)

Sex Differences in the Pressor and Tubuloglomerular Feedback Response to Angiotensin II

Hypertension (Dallas, Tex. 1979), 2012-01, Vol.59 (1), p.129-135

2012

Volltextzugriff (PDF)

Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo

British journal of pharmacology, 2016-02, Vol.173 (4), p.729-740

2016

Volltextzugriff (PDF)

Sex- and age-related differences in the chronic pressure-natriuresis relationship: role of the angiotensin type 2 receptor

American journal of physiology. Renal physiology, 2014-10, Vol.307 (8), p.F901-F907

2014

Volltextzugriff (PDF)

Angiotensin-(1–7) Acts as a Vasodepressor Agent Via Angiotensin II Type 2 Receptors in Conscious Rats

Hypertension (Dallas, Tex. 1979), 2005-05, Vol.45 (5), p.960-966

2005

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(209)

Publikationsform

Artikel
(227)
Buchkapitel
(3)

Sprache

Englisch
(230)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors

Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats

Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis

Optimising the photothrombotic model of stroke in the C57BI/6 and FVB/N strains of mouse

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice

Differential phenotypes of tissue-infiltrating T cells during angiotensin II-induced hypertension in mice

The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model

Nitroxyl (HNO): the Cinderella of the nitric oxide story

Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis

In Aged Females, the Enhanced Pressor Response to Angiotensin II Is Attenuated By Estrogen Replacement via an Angiotensin Type 2 Receptor-Mediated Mechanism

The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice

Anti-fibrotic Potential of AT2 Receptor Agonists

Novel AT2R agonist, β-Pro7Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats

Protective arms of the renin-angiotensin-system in neurological disease

Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice

Renal functional effects of the highly selective AT2R agonist, β-Pro7 Ang III, in normotensive rats

Reversal of Vascular Macrophage Accumulation and Hypertension by a CCR2 Antagonist in Deoxycorticosterone/Salt-Treated Mice

The protective effects of a novel AT2 receptor agonist, β-Pro7Ang III in ischemia-reperfusion kidney injury

Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo

The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy

β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats

Sex Differences in the Pressor and Tubuloglomerular Feedback Response to Angiotensin II

Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo

Sex- and age-related differences in the chronic pressure-natriuresis relationship: role of the angiotensin type 2 receptor

Angiotensin-(1–7) Acts as a Vasodepressor Agent Via Angiotensin II Type 2 Receptors in Conscious Rats

Suchergebnisse filtern